Tech Company Financing Transactions
RhinoCyte Funding Round
On 10/7/2015, RhinoCyte landed $250 thousand in financing from private investors.
Transaction Overview
Company Name
Announced On
10/7/2015
Transaction Type
Debt
Amount
$250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 East Jefferson St. 135
Louisville, KY 40202
USA
Louisville, KY 40202
USA
Phone
Website
Email Address
Overview
RhinoCyte Inc. is a biopharmaceutical company focused on developing innovative treatments using stem cells taken from the nose lining of adults. The company's goal is to extend and enhance patients' quality of life through regenerative medicine treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Fred Roisen
Co-Founder
Steve Gailar
Browse more venture capital transactions:
Prev: 10/7/2015: ESS venture capital transaction
Next: 10/7/2015: Tellspec venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs